Abstract Background and Purpose Currently there are no widely accepted guidelines for
chimerism analysis testing in hematopoietic cell transplantation (HCT) patients. The …

With advances in allogeneic hematopoietic stem cell transplant (allo-HCT), disease relapse
has replaced transplant-related mortality as the primary cause of treatment failure for …

Pediatric and young adult (YA) patients with acute myeloid leukemia (AML) who relapse
after allogeneic hematopoietic cell transplantation (HCT) have an extremely poor prognosis …

This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

Allogeneic hematopoietic stem cell transplantation (HSCT) offers potentially curative
treatment for many children with high-risk or relapsed acute leukemia (AL), thanks to the …

Clinical outcomes for children with acute myeloid leukemia (AML) have improved minimally
during the past 4 decades despite maximally intensive chemotherapy, hematopoietic stem …

Introduction The field of allogeneic hematopoietic cell transplantation (allo‐HCT) began in
the 1950s, and despite a seven decade history of remarkable clinical advances, graft‐versus …

The efficacy of donor lymphocyte infusion (DLI) without chemotherapy was investigated and
compared with that of chemotherapy prior to DLI (Chemo-DLI) in patients who were minimal …

Although generally not applied as first-line treatment of multiple myeloma, allogeneic
hematopoietic cell transplantation (allo-SCT) can still be chosen as ultimate escalation …

Introduction Total body irradiation (TBI)‐based conditioning is the standard of care in the
treatment of acute lymphoblastic leukemia (ALL) that requires allogeneic hematopoietic …